|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-earning deposits with other banks | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investment securities held-to-maturity (fair value $102,497 and $109,724 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Investment securities available-for-sale (amortized cost $408,196 and $398,476, net of allowance for credit losses of $34 and $11 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Investments in equity securities | ||||||||||||||||||||
| Federal Home Loan Bank, Federal Reserve Bank and other stock, at cost | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans and leases receivable, net of deferred income | ||||||||||||||||||||
| Loans and leases held for investment | ||||||||||||||||||||
| Less: Allowance for credit losses, loans and leases | ||||||||||||||||||||
| Net loans and leases held for investment | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangibles, net of accumulated amortization | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Accrued interest receivable and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Noninterest-bearing deposits | ||||||||||||||||||||
| Interest-bearing deposits | ||||||||||||||||||||
| Total | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Subordinated notes | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Accrued interest payable and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Common stock, $5 par value: 48,000,000 shares authorized at June 30, 2026 and December 31, 2025; 31,556,799 shares issued at June 30, 2026 and December 31, 2025; 27,585,768 and 28,156,917 shares outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of tax benefit | ||||||||||||||||||||
| Treasury Stock, Common, Shares | ||||||||||||||||||||
| Treasury stock, at cost; 3,971,031 and 3,399,882 shares at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity |
Loading...
